Abstract Spinal cord injury has become a global public health challenge. Astragaloside IV has been shown to have neuroprotective effects. However, the underlying mechanism of astragaloside IV against spinal cord injury remains poorly understood. An integrated approach combining network pharmacology, in vivo experimental validation, molecular docking, molecular dynamics simulation, and metabolomics was used to investigate the underlying mechanism of astragaloside IV against spinal cord injury.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Xiongjie
Contact Xiongjie, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack